A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
| Excerpt | Reference |
|---|
| "Nineteen chondrosarcomas are reported arising in proximal phalanges or metacarpal bones of the hand mainly in elderly patients, predominantly women." | ( Price, CH; Roberts, PH, 1977) |
| "Chondrosarcomas are infrequently found in the head and neck region." | ( Lacovara, J; Patterson, K; Reaman, GH, 1992) |
| "Dedifferentiated chondrosarcoma is a biphasic tumour, comprising well-differentiated chondrosarcoma and an anaplastic non-cartilaginous sarcoma juxtaposed but distinct from each other." | ( Dervan, PA; Hurson, BJ; O'Loughlin, J, 1988) |
| "Chondrosarcoma is a rare complication in hereditary multiple exostoses." | ( Bobin, JY; Bouvier, JF; Brunat-Mentigny, M; Chassard, JL; Domenach, M; Lahneche, BE; Mayer, M; Riffat, G; Roojee, N, 1986) |
| "Parosteal chondrosarcoma is a tumour of the soft tissues different from juxta-cortical chondrosarcoma." | ( Carbillet, JP; Pinon, P; Tropet, Y; Vichard, P; Watelet, F, 1980) |
| "Although myxoid chondrosarcoma is a slow-growing tumor, it has a high potential for metastases." | ( Abramovici, LC; Bonar, F; Steiner, GC, 1995) |
| "Within this group, chondrosarcoma is exceedingly rare, with only 1 case having been reported." | ( Aueron, F; Brener, BJ; Brief, DK; Clark, N; Goldenkranz, RJ; Hertz, S; Huston, J; Maeuser, H; Manicone, J; Omeish, E; Parsonnet, V, 1998) |
| "Chondrosarcomas are alleged to be resistant to chemotherapy." | ( Albino, AP; Devaney, K; Glantz, L; Healey, JH; Mak, S; Schwartz, GK; Terek, RM, 1998) |
| "Chondrosarcomas are malignant cartilage-forming tumors arising centrally in bone (central chondrosarcoma) or within the cartilaginous cap of osteochondroma (peripheral chondrosarcoma)." | ( Bovée, JV; Cleton-Jansen, AM; Hogendoorn, PC; van den Broek, LJ, 2000) |
| "Chondrosarcoma is currently defined as a malignant cartilage tumour arising de novo or within a pre-existing benign cartilage tumour." | ( Damiens, C; Gouin, F; Grimaud, E; Heymann, D; Passuti, N; Rousselle, AV, 2002) |
| "Chondrosarcoma is rare and most likely the result of malignant degeneration of a pre-existing lesion." | ( Bancroft, LW; O'Connor, MI, 2004) |
| "Chondrosarcoma is a malignant disease of cartilage." | ( Chen, WH; Liu, JS, 2005) |
| "Parafalcine chondrosarcoma is extremely rare, and may be difficult to differentiate preoperatively from falx meningioma." | ( Fukasawa, Y; Saito, N; Sasaki, A; Takahashi, A; Tosaka, M, 2005) |
| "Spinal chondrosarcoma are extremely rare and slowly growing tumors." | ( Domínguez, CJ; Joly, C; Martín-Ferrer, S; Rimbau, J, 2005) |
| "Chondrosarcoma is a malignant cartilaginous matrix-producing tumor that can be lethal in 10% to 50% of the patients." | ( Baelde, HJ; Bovée, JV; Cleton-Jansen, AM; Hogendoorn, PC; Karperien, M; van Beerendonk, HM, 2005) |
| "Chondrosarcoma is a malignant cartilage tumor that may arise from benign precursor lesions, such as enchondromas." | ( Alman, BA; Andrulis, IL; Gokgoz, N; Hopyan, S; Lin, AC; Nadesan, P; Poon, R; Tiet, TD; Wunder, JS; Yan, T, 2006) |
| "Chondrosarcoma is a difficult musculoskeletal tumor to treat." | ( Gouin, F; Heymann, D; Ory, B; Rédini, F, 2006) |
| "Chondrosarcoma is a rare flat bone neoplasm." | ( Batista De-Paula, AM; Coletta, RD; Ferreti Bonan, PR; Martelli Jùnior, H; Nogueira Dos Santos, LA, 2006) |
| "As chondrosarcomas are resistant to chemotherapy and ionizing radiation, therapeutic options are limited." | ( Abdollahi, A; Bertl, E; Ewerbeck, V; Gebhard, MM; Huber, PE; Klenke, FM; Sckell, A, 2007) |
| "Clear cell chondrosarcoma is a variant of conventional chondrosarcoma behaving as low grade malignant bone tumor." | ( Bacchini, P; Bella, CD; Bertoni, F; Colangeli, M; Colangeli, S; Donati, D; Yin, JQ, 2008) |
| "Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy." | ( Chou, MC; Fong, YC; Hsu, CJ; Hsu, HC; Hsu, SF; Lai, TJ; Lee, MC; Li, TM; Lin, JG; Yang, SF, 2007) |
| "Human chondrosarcomas are generally resistant to conventional treatments like chemotherapy and radiotherapy." | ( Brassat, U; Brümmendorf, TH; Fellenberg, J; Parsch, D, 2008) |
| "Myxoid chondrosarcoma is a slow-growing sarcoma poorly responsive to chemotherapy and radiation therapy." | ( Bernstein-Molho, R; Merimsky, O; Sagi-Eisenberg, R, 2008) |
| "Osteosarcoma and chondrosarcoma are the most common primary tumors of the chest wall." | ( Dernell, WS; Kamstock, DA; Liptak, JM; Monteith, GJ; Rizzo, SA; Withrow, SJ, 2008) |
| "Chondrosarcoma is still therefore considered a surgical disease despite its aggressive features of recurring locally and spreading to the lungs." | ( Horiuchi, K; Hornicek, FJ; Morii, T; Morioka, H; Susa, M; Toyama, Y; Weissbach, L; Yabe, H, 2009) |
| "Chondrosarcomas are notorious for their resistance to conventional chemotherapy and radiotherapy, indicating there are no curative treatment possibilities for patients with inoperable or metastatic disease." | ( Bovée, JV; Briaire-de Bruijn, IH; de Miranda, NF; Hogendoorn, PC; Schrage, YM; Taminiau, AH; van Oosterwijk, J; van Wezel, T, 2009) |
| "Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy." | ( Chen, YJ; Fong, YC; Hsu, SF; Li, TM; Liu, JF; Liu, SH; Su, YC; Tang, CH; Wu, CL, 2010) |
| "The myxoid chondrosarcoma is a rare tumour lesion, and according to the literature, only 2 % occur outside of the skeleton." | ( Evert, M; Lippert, H; Meyer, F; Mroczkowski, P; Tautenhahn, J, 2010) |
| "Chondrosarcomas are resistant to conventional chemo- and radiotherapy." | ( Bovée, JV; Briaire-de Bruijn, I; Kalinski, T; Llombart-Bosch, A; Machado, I; Meijer, D; Schrage, YM; Taminiau, AH; van den Akker, BE, 2010) |
| "Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy." | ( Chang, CS; Fong, YC; Kuo, SC; Liu, JF; Tang, CH; Yang, WH, 2010) |
| "Chondrosarcoma is a soft tissue sarcoma with a poor prognosis that is unresponsive to conventional chemotherapy." | ( Guo, W; Han, X; Lu, XC; Peng, CL; Ren, TT; Tang, GQ; Yan, TQ; Zhao, FL; Zhao, H, 2010) |
| "Chondrosarcomas are malignant cartilage tumors that do not respond to traditional chemotherapy or radiation." | ( Abdulkawy, H; Bischof, JM; Bonaldo, Mde F; Casavant, TL; Hamm, CA; Hendrix, MJ; Malchenko, S; Morcuende, JA; Seftor, EA; Soares, MB; Sredni, ST; Stevens, JW; Vanin, EF; Wang, D; Xie, H, 2010) |
| "About 5-12% of all chondrosarcomas are localized in base of skull region." | ( Combs, SE; Debus, J; Jensen, AD; Kieser, M; Münter, MW; Nikoghosyan, AV; Rauch, G, 2010) |
| "Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy." | ( Chang, CS; Chang, KW; Fong, YC; Kuo, SC; Liu, JF; Tang, CH, 2011) |
| "Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy." | ( Fong, YC; Jin, TR; Lee, CY; Li, TM; Tang, CH; Tzen, JT; Yang, WH, 2011) |
| "Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy." | ( Chang, CS; Fong, YC; Hsu, SF; Kao, ST; Li, TM; Lin, TY; Su, YC; Tang, CH; Wu, CM, 2011) |
| "Chondrosarcoma is a malignant primary bone tumor that is resistant to chemotherapy and radiation therapy." | ( Krajarng, A; Nakamura, Y; Suksamrarn, S; Watanapokasin, R, 2011) |
| "Chondrosarcoma is virtually resistant to chemotherapy and radiation therapy." | ( Balakrishnan, S; Campean, V; Grifka, J; Lechler, P; Renkawitz, T; Schaumburger, J; Tingart, M, 2011) |
| "Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis." | ( Chen, MY; Hsu, HC; Huang, CY; Lee, CY; Lin, CY; Tang, CH, 2011) |
| "Chondrosarcoma is the second most common primary bone tumor and it responds poorly to both chemotherapy and radiation treatment." | ( Chang, CS; Fong, YC; Kuo, SC; Liu, JF; Tang, CH, 2012) |
| "Chondrosarcomas are malignant cartilage-forming tumors notorious for their resistance to conventional chemo- and radiotherapy." | ( Bovée, JV; Briaire-de Bruijn, IH; Cleton-Jansen, AM; Gelderblom, H; Herpers, B; Meijer, D; van de Water, B; van Oosterwijk, JG, 2012) |
| "Chondrosarcoma is a malignant tumor in which the tumor cells produce cartilage but not bone." | ( Kalavathy, N; Katyayan, M; Katyayan, PA, 2011) |
| "Chondrosarcoma is a soft tissue sarcoma with a poor prognosis that is unresponsive to conventional chemotherapy." | ( Fong, YC; Lee, HP; Li, TM; Tang, CH; Tsao, JY, 2012) |
| "Chondrosarcoma is well known as a radioresistant tumor, but the mechanisms underlying that resistance are still unclear." | ( Held, KD; Kawamura, H; Magpayo, N; Wakatsuki, M, 2012) |
| "Chondrosarcomas are the second most frequent primary malignant type of bone tumor." | ( Besse, A; Blay, JY; Decouvelaere, AV; Dutour, A; Michot, JP; Perez, J; Pissaloux, D; Pointecouteau, T, 2012) |
| "Chondrosarcoma is a form of malignant skeletal tumor of cartilaginous origin." | ( Carlson, CS; Di Cesare, PE; Fierro, F; Gupta, K; Gupta, L; Haudenschild, DR; Kumari, R; Li, H; Nolta, J; Overn, P; Yik, JH, 2012) |
| "Clear cell chondrosarcoma is a rare cartilaginous bone tumor, and little is known about its pathology." | ( Endo, M; Ishii, T; Iwamoto, Y; Matsuura, S; Oda, Y; Setsu, N; Takahashi, Y; Tamiya, S; Yamamoto, H, 2013) |
| "Chondrosarcoma is a common soft tissue malignancy." | ( Chen, A; Dynlacht, JR; Garrett, J; Koizumi, M; Ogawa, K; Tanjung, NG; Teshima, T; Yokota, H; Yoshioka, Y, 2012) |
| "Chondrosarcoma is a type of highly malignant tumor with a potent capacity of local invasion and distant metastasis." | ( Chen, LM; Hsu, HH; Huang, CY; Lin, JA; Lin, YM; Tang, CH; Tsai, CH; Tsai, FJ; Wu, MH, 2013) |
| "Chondrosarcoma is the second most common sarcoma in bone malignancy and is characterized by a high metastatic potential." | ( Cheng, HC; Huang, CY; Lin, JA; Peng, CY; Tang, CH; Wang, SW; Wu, MH, 2014) |
| "Osteosarcoma and chondrosarcoma are malignant bone tumors, and they significantly affect the life quality of patients including children and adults." | ( Gao, W; Han, Y; Lu, T; Sha, B; Wang, S; Wu, J; Xu, F, 2013) |
| "Chondrosarcoma is notable for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and poor survival." | ( Charbonneau, C; Chen, Q; Sun, X; Terek, RM; Wei, L; Yang, W, 2013) |
| "Chondrosarcomas are notoriously resistant to cytotoxic chemotherapeutic agents." | ( Bovée, JV; Bühnemann, C; Demetri, GD; Hassan, AB; Moss, S; Remillard, SP; Sicinska, E; van Oosterwijk, JG; van Wezel, T; Wagner, AJ; Zhang, YX, 2013) |
| "Chondrosarcoma is the second most common primary bone tumor, and it responds poorly to both chemotherapy and radiation treatment." | ( Hsiao, CJ; Lee, TH; Liu, SC; Su, CM; Tang, CH; Tzeng, WP; Wang, SW, 2013) |
| "Chondrosarcomas are the most frequent malignant bone tumor type in the hand." | ( Horch, RE; Schnürer, S, 2013) |
| "Chondrosarcoma is the primary malignancy of bone that is characterized by a potent capacity to invade locally and cause distant metastasis, and is therefore associated with poor prognoses." | ( Chang, SL; Fong, YC; Hsu, CJ; Lin, CY; Tang, CH, 2013) |
| "Chondrosarcomas are malignant cartilage-forming tumours of bone." | ( Bovée, JV; Briaire-de Bruijn, IH; Gelderblom, H; Herpers, B; van de Water, B; van Oosterwijk, JG; van Ruler, MA, 2013) |
| "Chondrosarcomas are malignant cartilage-forming tumors of bone which exhibit resistance to both chemotherapy and radiation treatment." | ( Nie, L; Wang, CP; Zhang, YF; Zhu, Z, 2014) |
| "chondrosarcoma is the most common primary tumor of the chest wall." | ( Al-Gamal, G; Al-Refaie, RE; Al-Shabrawy, M; Amer, S; Ismail, MF; Mokbel, E, 2014) |
| "Chondrosarcoma is a malignant tumor of cartilage in which there is ligand-dependent activation of Hh signaling." | ( Ali, SA; Alman, BA; Apte, SS; Campbell, VT; Keilty, J; McGovern, K; Nadesan, P; Poon, R; Proctor, J; Wang, CY; Wang, LW; Wei, Q; Whetstone, H; Wunder, JS, 2014) |
| "Chondrosarcomas are malignant cartilage-forming tumors which are resistant to conventional chemotherapy and radiotherapy." | ( Cui, MY; Guo, YQ; Li, G; Li, XG; Liu, D; Shen, JH; Shi, FJ; Song, YD; Sun, YX; Wang, DY; Zhang, KF; Zhang, L, 2014) |
| "Chondrosarcoma is a malignant cartilage-forming cancer composed of cells derived from transformed cells that produce cartilage." | ( Hua, G; Li, X; Liu, Y; Luo, Y; Xu, P, 2014) |
| "Chondrosarcoma is a type of malignant bone tumor secreting cartilage-like matrix." | ( Cheng, W; Gong, C; Guo, F; Huang, X; Jiang, T; Wu, Y; Xiang, W; Xu, K; Yang, K, 2014) |
| "Because Chondrosarcoma is resistant to available chemotherapy and radiation regimens, wide resection is the mainstay in treatment, which frequently results in high morbidity and which may not prevent local recurrence." | ( Buckwalter, JA; Fredericks, DC; Malandra, AE; Morcuende, J; Odgren, PR; Otero, JE; Stevens, JW, 2014) |
| "Skull base chondrosarcomas are slow-growing, locally invasive tumors that arise from the petroclival synchondrosis." | ( Carrau, RL; Ditzel Filho, LF; Dolci, RL; Fiore, ME; Martinez, CA; Mesquita Filho, PM; Otto, BA; Prevedello, DM, 2014) |
| "Chondrosarcoma is a malignant cartilaginous tumor of the bone." | ( Bovée, JV; Karperien, M; Meijer, D; Plass, JR; Que, I; van Oosterwijk, JG, 2015) |
| "Chondrosarcoma is refractory to conventional chemotherapy." | ( Aoyagi, T; Hornicek, FJ; Ichimura, S; Mochizuki, K; Morii, T; Ohnishi, H; Ohtsuka, K; Yoshiyama, A, 2014) |
| "Chondrosarcoma is the most common primary malignant bone tumor in adults, has no effective systemic treatment, and patients with this disease have poor survival." | ( Charbonneau, C; Chen, Q; Sun, X; Terek, RM; Wei, L, 2015) |
| "Chondrosarcoma is the second frequent type of primary bone cancer." | ( Hamamura, K; Na, S; Wan, Q; Xu, W; Yan, JL; Yokota, H, 2015) |
| "Chondrosarcoma is a cartilage tumor and is the second most common malignant bone cancer." | ( Maran, A; Reumann, S; Shogren, KL; Yaszemski, MJ, 2016) |
| "Chondrosarcomas are malignant bone tumors that produce cartilaginous matrix." | ( Bodamer, O; Galoian, K; Hu, G; Johnson, B; Li, L; Paz, AC; Rosenberg, A; Tinoco, G; Trent, JC; Wilky, BA, 2015) |
| "While chondrosarcoma is mainly treated surgically, osteosarcoma therapy consists of both chemotherapy and surgical resection of the tumor." | ( Gosheger, G; Guder, WK; Hardes, J; Nottrott, M; Streitbürger, A, 2015) |
| "Chondrosarcoma is characterized for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and low rates of survival." | ( Kaltenegger, H; Kullich, W; Leithner, A; Lohberger, B; Steinecker-Frohnwieser, B; Stuendl, N, 2015) |
| "Chondrosarcoma is the second most common type of primary bone malignancy in the United States after osteosarcoma." | ( Deng, B; Ding, M; Feng, H; Gao, L; Guo, KJ; Hou, Y; Sun, W; Tang, XY; Yuan, F; Zheng, W, 2016) |
| "Chondrosarcoma is the second most frequently occurring type of bone malignancy that is characterized by the distant metastasis propensity." | ( Chang, AC; Chang, TM; Chang, YS; Fong, YC; Hsu, SK; Tang, CH; Wang, SJ; Wang, SW; Yang, WH, 2016) |
| "Chondrosarcoma is a malignant cartilage forming bone tumour for which no effective systemic treatment is available." | ( Bovée, JV; Briaire-de Bruijn, I; Cleton-Jansen, AM; Cleven, AH; Danen, EH; De Jong, Y; Fletcher, JA; Peterse, EF, 2016) |
| "Chondrosarcoma is a malignant tumor of mesenchymal origin predominantly composed of cartilage-producing cells." | ( Chen, HT; Hsieh, M; Huang, PH; Tang, CH; Tsai, CH; Wu, MH, 2016) |
| "Chondrosarcoma is a highly malignant cartilage-forming bone tumor that has the capacity to invade locally and cause distant metastasis." | ( Chang, CS; Chen, CY; Chen, HT; Liu, JF; Tang, CH, 2016) |
| "Chondrosarcoma is one of the bone tumor with high mortality in respond to poor radiation and chemotherapy treatment." | ( Chang, CS; Chen, CY; Huang, YL; Li, W; Lu, T; Su, CM; Sun, Y; Tang, CH; Tsai, CH, 2016) |
| "High grade chondrosarcoma is characterized by its lack of response to conventional cytotoxic chemotherapy, the tendency to develop lung metastases, and low survival rates." | ( Kaltenegger, H; Leithner, A; Lohberger, B; Rinner, B; Steinecker-Frohnwieser, B; Stuendl, N, 2016) |
| "Chondrosarcomas are malignant cartilage-forming tumors from low-grade to high-grade aggressive tumors characterized by metastasis." | ( Chen, J; Huang, K; Pan, F; Tang, YJ; Yang, MS, 2017) |
| "Although chondrosarcoma is a common malignant bone tumor, cases arising in the rib are relatively rare." | ( Matsuoka, K; Miyamoto, Y; Ueda, M, 2017) |
| "Chondrosarcoma is the second most malignant bone tumor with poor prognosis and limited treatment options." | ( Gao, XJ; Gui, T; Liang, GH; Liang, ZJ; Sang, Y; Tam, MS; Yang, J; Zha, ZG; Zhang, HT, 2017) |
| "Chondrosarcoma is a malignant hyaline cartilage forming tumor." | ( Ciupe, BC; Folescu, R; Hărăguş, HG; Iacob, M; MaliŢa, DC; Motoc, AGM; Pop, DL; Prejbeanu, R; Vermeşan, D; Zamfir, CL, 2017) |
| "Chondrosarcoma is a malignant primary bone tumor." | ( Chao, SC; Chen, YJ; Huang, KH; Huang, KY; Kuo, KL; Liu, SH; Tang, CH; Wang, CC; Yang, RS; Yang, TH, 2017) |
| "Chondrosarcoma is the second most common primary malignancy form of bone cancer, exhibiting resistance to chemotherapy and radiation therapy as well as developing high metastasis ability in late-stage tumors." | ( Chen, TM; Huang, YL; Lin, CY; Tang, CH; Tsai, CH; Yang, DY, 2017) |
| "Chondrosarcoma is the most common bone sarcoma in adults." | ( Davidson, D; Jones, RL; Katz, D; Loggers, ET; Pollack, SM; Rodler, ET, 2017) |
| "Chondrosarcoma is a malignant cartilage-forming bone tumour in which mutations in IDH1 and IDH2 frequently occur." | ( Addie, RD; Bovée, JVMG; Cleton-Jansen, AM; Cleven, AHG; de Jong, Y; Kruisselbrink, AB; Molenaar, RJ; Niessen, B; Peterse, EFP; van den Akker, BEWM, 2018) |
| "Chondrosarcoma is difficult to treat because of resistance to conventional chemotherapy and radiotherapy." | ( Diao, Y; He, Q; Hou, B; Huang, H; Li, Y; Liu, Y; Luo, J; Nie, J; Qi, L; Wu, M; Yang, D; Zhao, Y; Zhou, L, 2018) |
| "Chondrosarcomas are malignant tumors of the bone that exhibit resistance to chemotherapy and radiation." | ( Pan, J; Shen, M; Wu, R; Xing, C, 2018) |
| "Chondrosarcoma is characterized by the ability to produce extracellular matrix of cartilage." | ( Chen, JC; Huang, C; Lee, IN; Tang, CH; Wu, YP, 2018) |
| "Chondrosarcoma is a malignant cartilaginous neoplasm of the bone which resistant to radiation therapy and chemotherapy." | ( Li, Z; Liu, T; Ouyang, Z; Wang, S; Wang, W; Zeng, M; Zhang, Q, 2019) |
| "Enchondroma and chondrosarcoma are the most common benign and malignant cartilaginous neoplasms." | ( Al-Jazrawe, M; Alman, BA; Pathmanapan, S; Poon, R; Puviindran, V; Ramu, E; Tang, YJ; Tsushima, H; Wei, Q; Wunder, J; Zhang, H, 2019) |
| "Head and neck chondrosarcomas are incredibly rare with documented cases arising from skull base, maxilla, larynx, and nasal septum." | ( Rimmer, J; Tan, HB, 2019) |
| "Chondrosarcoma is the second-most malignant cancer of the bone and routine treatments such as chemotherapy and radiotherapy have not responded to the treatment of this cancer." | ( Alavi, SJ; Kheirollahi, M; Mohsenian, NB; Nia, AH; Shanei, A; Tavakoli, MB, 2019) |
| "Chondrosarcomas are malignant bone tumors refractory to chemotherapy and radiation treatment; thus, novel therapeutic strategies are required." | ( Brown, J; Galoian, KA; Granger, C; Hoyt, AK; Moran, A; Saigh, S; Sedani, A, 2019) |
| "Chondrosarcoma is the second most common malignant bone tumor." | ( Aikawa, Y; Chuman, H; Endo, M; Fujita, S; Fujiwara, T; Fukushima, S; Hattori, A; Hirose, T; Ishikawa, T; Iwamoto, Y; Katsumoto, T; Kawai, A; Kimura, A; Kitabayashi, I; Machida, Y; Matsumoto, Y; Matsunaga, H; Nakagawa, M; Nakashima, Y; Nakatani, F; Ogawara, Y; Seki, T; Setsu, N; Shimada, E; Soga, T; Yahiro, K; Yamagata, K; Yokoyama, N, 2019) |
| "Chondrosarcoma is the second most common primary bone sarcoma." | ( Abzug, JM; Alferiev, I; Cellini, A; Chorny, M; Dan, Y; Enomoto-Iwamoto, M; Garcia, S; Iwamoto, M; Moritani, N; Ng, VY; Shield, WP; Takigawa, M; Tian, H; Wilson, K, 2020) |
| "Chondrosarcoma is the second most common form of bone cancer and is characterized by its ability to produce an extracellular matrix of the cartilage." | ( Chen, JC; Hsieh, MJ; Huang, C; Huang, HC; Lee, IN; Lin, CC; Lin, CY; Tang, CH, 2020) |
| "Chondrosarcoma is the second most common malign bone tumor in adults." | ( Bekeschus, S; Ekkernkamp, A; Haralambiev, L; Jacoby, JM; Mustea, A; Nitsch, A; Stope, MB; Strakeljahn, S, 2020) |
| "Osteosarcoma and chondrosarcoma are sarcomas of the bone and the cartilage that are primarily treated by surgical intervention combined with high toxicity chemotherapy." | ( Ananieva, EA; Boyer, MP; Fifelski, NA; Martin, AA; Martin, SB; Nack, DL; Radlwimmer, B; Reiche, WS; Schultz, AJ; Stanford, SJ, 2020) |
| "Chondrosarcomas are well known for their resistance to chemotherapeutic agents, including cisplatin, which is commonly used in chondrosarcomas." | ( Chang, HC; Cheng, SP; Fong, YC; Han, CK; Huang, YL; Huang, YW; Liao, KW; Lin, CY; Tang, CH; Tsai, HC; Wang, SW; Wu, WT, 2020) |
| "High-grade chondrosarcomas are chemo- and radio-resistant cartilage-forming tumors of bone that often relapse and metastase." | ( Ahire, V; Chevalier, F; Ho Kim, E; Nakajima, T; Romeo, PH; Sai, S; Saintigny, Y; Sunada, S; Vares, G; Yamamoto, T, 2020) |
| "Chondrosarcomas are malignant bone tumors." | ( Benmoussa, A; Brotin, E; Contentin, R; Demoor, M; Denoyelle, C; Duchemin, A; Galéra, P; Lafont, JE; Legendre, F; Poulain, L; Saintigny, Y; Veys, C, 2021) |
| "Chondrosarcoma is rarely found in the extremities but it remains the most common primary malignant bone tumor of the hand." | ( Cermak, K; Kinnen, L; Ollero, P; Vanden Dungen, S, 2021) |
| "As chondrosarcoma is a rare bone neoplasm, it must be considered in the differential diagnosis of lower back pain to initiate adequate treatment." | ( Frank, BJH; Kocijan, R; Lomoschitz, F; Resch, H; Simon, S, 2023) |
| "Enchondromas and chondrosarcomas are common cartilage neoplasms that are either benign or malignant, respectively." | ( Alman, BA; Ban, GI; Ding, X; Karner, CM; Nadesan, P; Puviindran, V; Shen, L; Tang, YJ; Tsushima, H; Yahara, Y; Zhang, GF; Zhang, H, 2022) |
| "Chondrosarcoma is the second-most common primary malignant bone tumor but chondrosarcoma of small bones of the hand is extremely rare, representing less than 2% of all cases, with exceedingly rare skin metastases." | ( Correia, C; Fernandes, S; Filipe, P; Kutzner, H; Soares-de-Almeida-, L, 2022) |
| "Although chondrosarcoma is the second most common primary malignant bone tumor, treatment options are limited due to its extensive resistance to a chemo- and radiation therapy." | ( Bauer, R; Eck, N; Glänzer, D; Kaltenegger, H; Kretschmer, N; Leithner, A; Lohberger, B; Steinecker-Frohnwieser, B, 2022) |
| "Chondrosarcoma is the second most common sarcoma of bone, accounting for about 25% of primary bone tumors." | ( Abdel Aal, MM; Azmy, SI; El Masry, AM; Mustafa, MAR, 2023) |
| "Chondrosarcoma is the second most common type of bone cancer." | ( Chen, JC; Chong, ZY; Guo, JH; Huang, C; Huang, HC; Lin, CY; Shih, HC; Tang, CH, 2023) |
| "Chondrosarcomas are well known for their resistance to conventional chemotherapy and radiotherapy treatment regimens, which is particularly detrimental in patients who have unresectable tumors." | ( Boveé, JVMG; Briaire-de Bruijn, IH; Palubeckaitė, I; van den Akker, BEWM; Venneker, S, 2023) |
| "Chondrosarcomas are primary malignant cartilage tumors with poor prognosis and high metastatic potential." | ( Chang, TY; Lan, KC; Liu, SH; Sheu, ML; Wu, CH; Yang, RS, 2023) |
| "Chondrosarcoma is ineffective for conventional radiotherapy and chemotherapy with a poor prognosis." | ( Fang, Q; Liu, W; Liu, Y; Sun, Y; Zhang, C, 2023) |
| "Chondrosarcoma is the second most common type of bone cancer." | ( Cheng, FJ; Chou, MC; Fong, YC; Huang, WC; Huang, YL; Huang, YW; Ko, CY; Lai, CY; Law, YY; Lin, CY; Tang, CH; Tran, NB; Tsai, CH; Wu, YY, 2023) |